Vor Biopharma Inc.VORNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-1.07%
↓ 101% below average
Average (6y)
99.43%
Historical baseline
Range
High:409.97%
Low:-1.07%
Volatility
413.4%
High variability
| Period | Value |
|---|---|
| 2024 | -1.07% |
| 2023 | 46.11% |
| 2022 | 35.81% |
| 2021 | 50.32% |
| 2020 | 409.97% |
| 2019 | 154.83% |
| 2018 | 0.00% |